MAPK8 and infection: To confirm the above results, RAW264.7 cells were pretreated with the NF-κB p65 specific inhibitor SC-514, the ERK specific inhibitor U-0126, and the JNK specific inhibitor SP600125 for 30 min before Ms_YrbE3A and BCG_YrbE3A infection [21,22,23].